[1]
С. В. Головко, “The Role of the Latest Biomarkers, the Gleason Tertiary Index, and Comorbid Status in Improving the Detection of High-risk Hormone-untreated Non-metastatic Prostate Cancer”, HM, no. 2, pp. 86–91, Jun. 2020.